UPLOAD Filing
PURPLE BIOTECH LTD.
Date: July 15, 2025 · CIK: 0001614744 · Accession: 0000000000-25-007451
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Purple Biotech Ltd. Draft Registration Statement on Form F-1 Submitted July 10, 2025 CIK No. 0001614744 Dear Gil Efron:
July 15, 2025
Gil Efron Chief Executive Officer Purple Biotech Ltd. 4 Oppenheimer Street Science Park Rehovot 7670104, Israel
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jayun Koo
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 15, 2025 Gil Efron Chief Executive Officer Purple Biotech Ltd. 4 Oppenheimer Street Science Park Rehovot 7670104, Israel Re: Purple Biotech Ltd. Draft Registration Statement on Form F-1 Submitted July 10, 2025 CIK No. 0001614744 Dear Gil Efron: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jayun Koo </TEXT> </DOCUMENT>